Huzhou Central Hospital Hospital
Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
China
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership